An Open-label(Part1), Single Arm(Part1), Randomized(Part2), Double-blind(Part2), Active-controlled(Part2), Phase III Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children
Phase of Trial: Phase III
Latest Information Update: 10 Nov 2016
At a glance
- Drugs GC 3110A (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Green Cross
- 04 Nov 2016 Status changed from active, no longer recruiting to completed.
- 16 Jun 2016 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016.
- 16 Jun 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Jul 2016.